Patient And Physician Preferences For Front-Line Treatment Of Advanced Stage Hodgkin Lymphoma In Germany, France And The United Kingdom

Introduction: The standard treatment regimens for advanced-stage Hodgkin lymphoma (HL) are adriamycin/bleomycin/vinblastine/dacarbazine (ABVD) and escalated dose bleomycin/etoposide/ adriamycin/cyclophosphamide/vincristine/procarbazine/prednisone (BEACOPPesc) in patients under age 60. The objective of this study was to understand drivers of treatment preferences among patients and physicians for choice of front-line treatments in advanced stage HL.